enGene Holdings Inc.
ENGN
$8.65
-$0.17-1.87%
NASDAQ
07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 27.11M | 24.95M | 25.49M | 23.98M | 22.57M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 101.14M | 87.95M | 78.14M | 62.30M | 55.28M |
Operating Income | -101.14M | -87.95M | -78.14M | -62.30M | -55.28M |
Income Before Tax | -94.21M | -79.63M | -69.02M | -55.16M | -122.36M |
Income Tax Expenses | 516.00K | 248.00K | 29.00K | -19.00K | -21.00K |
Earnings from Continuing Operations | -94.72 | -79.88 | -69.05 | -55.14 | -122.34 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -94.72M | -79.88M | -69.05M | -55.14M | -122.34M |
EBIT | -101.14M | -87.95M | -78.14M | -62.30M | -55.28M |
EBITDA | -100.78M | -87.64M | -77.85M | -62.03M | -55.00M |
EPS Basic | -1.90 | -1.65 | -1.53 | -1.51 | -119.09 |
Normalized Basic EPS | -1.18 | -1.03 | -0.95 | -0.93 | -23.75 |
EPS Diluted | -1.90 | -1.65 | -1.53 | -1.51 | -119.09 |
Normalized Diluted EPS | -1.18 | -1.03 | -0.95 | -0.93 | -23.75 |
Average Basic Shares Outstanding | 197.53M | 190.60M | 179.02M | 151.25M | 107.52M |
Average Diluted Shares Outstanding | 197.53M | 190.60M | 179.02M | 151.25M | 107.52M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |